{
    "nctId": "NCT04350021",
    "briefTitle": "Effect of Low Dose Metronomic Chemotherapy in Metastatic Breast Cancer",
    "officialTitle": "Effect of Low Dose Metronomic Chemotherapy in Metastatic Breast Cancer - a Two Step Study With a Retrospective Analyses Followed by a Translational Phase II Study",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer Metastatic, Chemotherapy Effect",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 40,
    "primaryOutcomeMeasure": "Overall response rates",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Written and informed consent\n* Breast cancer confirmed by histology\n* Recurrence (local or distant) not possible to cure\n* Measurable or evaluable disease\n* Life expectancy of more than tree months\n* ECOG (Eastern Cooperative Oncology Group) performance 0-2\n* No or any lines of previous therapies for recurrent disease.\n* Adequate contraception for patients of Child bearing age.\n\nExclusion Criteria:\n\n* Clinically significant cardiovascular disease\n* Non healing wound, Active peptic ulcer or bone fracture\n* Evidence of any other disease that puts the patient at high risk for treatment-related complications",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}